GLCRX
Price
$32.74
Change
-$0.03 (-0.09%)
Updated
Dec 3 closing price
Net Assets
1.64B
RGACX
Price
$86.23
Change
+$0.52 (+0.61%)
Updated
Dec 3 closing price
Net Assets
338.91B
Interact to see
Advertisement

GLCRX vs RGACX

Header iconGLCRX vs RGACX Comparison
Open Charts GLCRX vs RGACXBanner chart's image
Goldman Sachs Large Cap Gr Insghts R
Price$32.74
Change-$0.03 (-0.09%)
VolumeN/A
Net Assets1.64B
American Funds Growth Fund of Amer R3
Price$86.23
Change+$0.52 (+0.61%)
VolumeN/A
Net Assets338.91B
GLCRX vs RGACX Comparison Chart in %
View a ticker or compare two or three
VS
GLCRX vs. RGACX commentary
Dec 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GLCRX is a Buy and RGACX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGACX has more cash in the bank: 339B vs. GLCRX (1.64B). RGACX pays higher dividends than GLCRX: RGACX (0.07) vs GLCRX (0.00). GLCRX was incepted earlier than RGACX: GLCRX (18 years) vs RGACX (24 years). GLCRX (1.20) is less costly to investors than RGACX (0.94). GLCRX is a more actively managed with annual turnover of: 215.00 vs. RGACX (25.00). GLCRX has a lower initial minimum investment than RGACX: GLCRX (0) vs RGACX (250). RGACX annual gain was more profitable for investors over the last year : 6.46 vs. GLCRX (1.65). RGACX return over 5 years is better than : 29.83 vs. GLCRX (-18.69).
GLCRXRGACXGLCRX / RGACX
Total Expense Ratio1.170.94124%
Annual Report Gross Expense Ratio1.200.94128%
Fund Existence18 years24 years-
Gain YTD14.87318.55880%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets1.64B339B0%
Annual Yield % from dividends0.000.07-
Returns for 1 year1.656.4626%
Returns for 3 years32.9760.0955%
Returns for 5 years-18.6929.83-63%
Returns for 10 years42.6589.9047%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NEPH5.430.20
+3.80%
Nephros
WTFCN26.34-0.03
-0.11%
Wintrust Financial Corp
HSIC71.65-1.46
-2.00%
Henry Schein
PTLO4.94-0.14
-2.76%
Portillo's
NRIX16.35-0.56
-3.31%
Nurix Therapeutics